Cargando…

Retrospective study of proarrhythmic effects of levosimendan during the therapy of heart failure

Detalles Bibliográficos
Autores principales:	Zima, E, Szucs, G, Soltesz, A, Becker, D, Fulop, G, Molnar, L, Barczi, G, Merkely, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095278/ http://dx.doi.org/10.1186/cc5385

Ejemplares similares

Levosimendan therapy does not improve survival of post-resuscitation cardiogenic shock patients
por: Soos, P, et al.
Publicado: (2009)

Percutaneous coronary intervention in acute coronary syndrome complicated by states Killip 3 and 4 in 2005
por: Zima, E, et al.
Publicado: (2007)

Acute liver failure induced by intravenous amiodarone in the cardiac care unit: retrospective study of 3 years
por: Zima, E, et al.
Publicado: (2009)

Hemodynamic effects of levosimendan in patients with low-output heart failure
por: Gharsallah, H, et al.
Publicado: (2008)

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

Magnitude of first medical contact in the long-term prognosis of patients treated with STEMI
por: Becker, D, et al.
Publicado: (2010)

Levosimendan in trauma patients with acute cardiac failure
por: Afonin, AN, et al.
Publicado: (2011)

Preoperative treatment with levosimendan helps to evaluate myocardial reserves in cardiosurgical patients with chronic heart failure
por: Eremenko, A, et al.
Publicado: (2015)

Combined effects of ivabradine with dobutamine or levosimendan in isolated perfused hearts
por: Konrad, D, et al.
Publicado: (2013)

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004)

Efficacy of levosimendan in shock
por: McLean, A, et al.
Publicado: (2004)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

Treatment of calcium channel blocker overdose with levosimendan
por: Sencan, A, et al.
Publicado: (2011)

Influence of temperature on the cardiac action of dobutamine and levosimendan in isolated perfused hearts
por: Aldenhoff, U, et al.
Publicado: (2013)

Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study
por: Selli, Anders Lund, et al.
Publicado: (2023)

Levosimendan: experience of an adult ICU
por: Lippett, S, et al.
Publicado: (2006)

Levosimendan in patients with acute cardiogenic shock, not responders to conventional therapy
por: Vetrugno, L, et al.
Publicado: (2007)

Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in compensated chronic heart failure patients treated with levosimendan
por: Figueiredo, EJ de Almeida, et al.
Publicado: (2007)

Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study
por: Garratt, C, et al.
Publicado: (2004)

Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in decompensated chronic heart failure patients treated with levosimendan
por: Ferri, MB, et al.
Publicado: (2006)

Levosimendan versus dobutamine in septic shock
por: Alhashemi, JA, et al.
Publicado: (2009)

Levosimendan versus dobutamine in cardiac surgery
por: Delgado-Amaya, MD, et al.
Publicado: (2015)

Levosimendan in the emergency department: a useful tool to improve cellular perfusion
por: Devia, G, et al.
Publicado: (2015)

The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure
por: Michalopoulou, H, et al.
Publicado: (2007)

Hemodynamic effects of the new calcium sensitiser levosimendan in cardiosurgical ICU patients
por: Iasonidou, C, et al.
Publicado: (2004)

Levosimendan in myocardial depression due to severe sepsis
por: Malik, M, et al.
Publicado: (2007)

Levosimendan versus dobutamine in Tako-tsubo cardiomyopathy
por: Righetti, FR, et al.
Publicado: (2013)

Use of levosimendan in myocardial dysfunction due to sepsis
por: Vaitsis, J, et al.
Publicado: (2009)

Haemodynamic effects of levosimendan following cardiac surgery
por: Slezina, A, et al.
Publicado: (2009)

Utilization of levosimendan in the cardiac ICU: case series
por: Filipescu, D, et al.
Publicado: (2009)

Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018)

Levosimendan in critically ill adults: a utilisation review
por: Aron, J, et al.
Publicado: (2013)

Hemodynamic and volumetric response to levosimendan in critical care patients
por: Turani, F, et al.
Publicado: (2004)

Levosimendan use in critical care - a case series
por: Gibson, C, et al.
Publicado: (2015)

Levosimendan reduces pulmonary vascular resistance: clinical echocardiographic study
por: Nalos, M, et al.
Publicado: (2004)

Effects of levosimendan and inhaled nitric oxide on microcirculation in septic shock
por: Morelli, A, et al.
Publicado: (2009)

Systemic and regional effects of levosimendan and arginine–vaopressine in endotoxin-treated rabbits
por: Kaskos, H, et al.
Publicado: (2004)

Hemodynamic and echographic effects of levosimendan in patients with cardiogenic shock refractory to catecholamines
por: Labbene, I, et al.
Publicado: (2006)

Levosimendan does not improve resuscitation success after hypovolemic cardiac arrest
por: Semenas, E, et al.
Publicado: (2008)

Levosimendan: use, cost-effectiveness and outcome in a tertiary cardiothoracic centre
por: Ranjan, A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p90v9e5149frkpf9ae42gk20lb